Decoy Therapeutics is trading at $2.76, down 10.68% on September 28, 2026, amid broader risk-off pressure; no fresh company-specific catalyst was identified.
- Reuters reported U.S. futures fell after President Trump rejected Iran’s proposal, pushing crude higher and reigniting inflation concerns.
- Major indexes were also lower, consistent with cautious sentiment. This is market context, not a confirmed company-specific cause.